Incresync 25/15mg tablets for type 2 diabetes management. Combination of alogliptin and pioglitazone. Helps improve blood sugar control effectively./Description: Incresync 25/15mg is an oral antidiabetic medication indicated for adults with type 2 diabetes mellitus to improve glycemic control. It combines two active ingredients: alogliptin, a DPP-4 inhibitor that enhances insulin secretion and reduces glucagon levels, and pioglitazone, a thiazolidinedione that improves insulin sensitivity. This dual-action therapy is prescribed when single therapy is inadequate to control blood glucose levels. Incresync is used alongside diet and exercise to help lower fasting and postprandial blood sugar. It offers a convenient option for patients needing combined therapy in a single tablet. Each pack contains 28 film-coated tablets.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
